2026 Playbook for Specialty Medication Onboarding & Adherence
Specialty medications are reaching a tipping point. With 50+ novel drugs launching annually and 98 million prescriptions abandoned in 2024, traditional approaches to patient onboarding are breaking down. Prior authorization delays, fragmented workflows, and disconnected patient support programs create friction at every stage.
Why this matters now:
More medicare drug price negotiations start January 2026. As margins tighten and competition intensifies, brands that connect provider insights, PA requirements, patient engagement, and support programs will define what access and adherence look like in the years ahead.
This playbook shows you how to make that shift before your competitors do.
Why upstream intervention wins.
How engaging patients moments after prescribing delivers better outcomes than trying to recover abandoned scripts downstream.
The hidden cost of prescription abandonment.
What’s really at stake when 98 million prescriptions go unfilled, from patient outcomes to your competitive position.
The ROI of integrated platforms.
Real results from brands using unified provider-to-patient engagement, including one that achieved a 6% incremental lift in first fills.